TP53 and acute lymphoblastic leukemia: Owing to this low rate of TP53 mutation in refractory or relapsed BCP-ALL, P53 is expected to be inactivated as it acquires abnormalities in the mechanisms regulating it (as opposed to through TP53 mutations).